UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

4 May 2012

First stone in UCB’s new Swiss biotechnology production unit to be set

Read More
3 May 2012

Acquisition of own shares in the framework of employees’ long-term incentive plans

Read More
26 Apr 2012

UCB moving ahead to become patient-centric biopharmaceutical leader

Read More
26 Apr 2012

Acquisition of own shares in the framework of employees’ long-term incentive plans

Read More
26 Apr 2012

New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinson’s disease

Read More
26 Apr 2012

Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology

Read More

Stay up-to-date on the latest news and information from UCB